Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px
Document › Details

Kiadis Pharma N.V.. (6/13/17). "Press Release: Kiadis Pharma Raises €5 Million in Private Placement with Institutional Investors [Not for US, AU, CA, JP, ZA or any other jurisdiction where unlawful]". Amsterdam.

Organisations Organisation Kiadis Pharma N.V. (Euronext: KDS)
  Group Kiadis (Group)
  Organisation 2 Chardan Capital Markets LLC
Products Product investment banking
  Product 2 ATIR™ (Kiadis)
Index term Index term Kiadis–SEVERAL: investment, 201706 private placement €5m w 746k new shares €6.7/share = 11% discount to institutioal investors
Person Person Lahr, Arthur (Kiadis 201704– CEO before Crucell 200701 Chief Strategy Officer + EP Sales + BusDev)

Record changed: 2017-06-21


Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

More documents for Kiadis (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [LSUS] – The Business Web Portal 600x60px

» top